Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: daclatasvir
What it is used for
DAKLINZA is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults [see CLINICAL TRIALS and DOSAGE AND ADMINISTRATION].
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
A light green, biconvex, pentagonal film-coated tablet with "BMS" debossed on one side and "215"debossed on the other side
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient daclatasvir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Hep C treatment - Hepatitis NSW :Hepatitis NSW
Hepatitis NSW does not want to appear to give preference or prominence to one treatment regime over another. This factsheet relates to these hepatitis C treatment drugs (in alphabetical order):
Read more on Hepatitis NSW website
Hep C Treatments - Haemophilia Foundation Australia
An introduction to information on haemophilia, von Willebrand Disorder and related bleeding disorders and related information on hepatitis C and HIV.
Read more on Haemophilia Foundation Australia website